Abstract
In a previous paper entitled “The Graft Survival Curve: Ideology & Rhetoric” [1], I attempted to understand and interpret the significance of the common language and concepts used by members of the transplantation community, with respect to the graft survival statistic and its visual representation, the graft survival curve. In the course of this analysis, it became clear that there were many scientific dimensions as well as possible political agendas in the presentation and promotion of survival statistics and survival curves. First, proper clinical studies and clinical trials use this type of primary or secondary endpoint associated with testing a hypothesis either with retrospective analysis or prospective methodology. Second, the same type of endpoint outcome measure is derived from the voluntary submission of data sent to various local, national and international registries. What became very clear in analyzing the nature of and the statements about graft survival statistics was that they obscurely reflected the continuation of a long-standing confrontation that has been known in the field of clinical transplantation: the battle over control of the rules of organ rationing between the cadres of immunologists and clinicians.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Guttmann RD. The graft survival curve: ideology and rhetoric. Transplant Proc 1992; 24: 2407–10.
Medawar PB. The behavior and fate of skin autografts and skin homografts in rabbits. J Anatomy 1944; 78: 176–96.
Lowy I. Variances in meaning in discovery accounts: the case of contemporary biology. Hist Stud Phys Biol 1990; 21: 87–121.
Gjertson DW, Terasaki PI. The large center variation in half-lives of kidney transplants. Transplantation 1992; 53: 357–62.
Aswad S, Mann SL, Khetan U, et al. Omit HLA matching to attain shorter cold ischemic time? Transplant Proc 1993; 25: 3053–5.
Najarian JS, Gillingham KJ, Sutherland DER, et al. The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation 1994; 57: 812–6.
Dausset J, Hors J, Busson M, et al. Serologically defined hl-a antigens and long-term survival of cadaver kidney transplants. New Engl J Med 1974; 290: 979–84.
Opelz G. HLA matching should be utilized for improving kidney transplant success rates. Transplant Proc 1991; 23: 46–50.
Kasiske BL, Neylan JF, Riggio RR, et al. The effect of race on access and outcome in transplantation. New Engl J Med 1991; 324: 302–7.
Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. Transplantation 1994; 57: 1064–8.
Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts. New Engl J Med 1992; 327: 840–5.
Gjertson DW, Terasaki PI, Takemoto BS, et al. National allocation of cadaveric kidneys by hla matching. New Engl J Med 1991; 324: 1032–6.
Cecka JM, Cho YW, Terasaki PI. Analyses of the UNOS Scientific Renal Transplant Registry at three years - early events affecting transplant success. Transplantation 1992; 53: 59–64.
Wujcia T, Opelz G. A proposal for improved cadaver kidney allocation. Transplantation 1993; 56: 1513–7.
Thorogood DJ, Schreuder GMTH, Persijn GG, van Rood JJ. Organ sharing based on HLA matching saves dialysis years and patient lives. Transplant Proc 1993; 25: 3049–50.
Thorogood DJ. Statistical modelling of renal allograft survival and associated prognostic factors, The Hague, The Netherlands: Pasmans Offsetdrukkerij BV, 1992.
Veatch RM. Who empowers medical doctors to make allocative decisions for dialysis & organ transplantation? In Land W, Dossetor JB, editors. Organ replacement therapy: ethics, justice and commerce. Berlin: Springer-Verlag, 1991: 331–5.
Veatch RM. The technical criteria fallacy. Hastings Center report 1977; August: 15–16.
Calvino I. Mr. Palomar. Toronto: Lester & Orpen Dennys Ltd., 1994: 109.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Guttmann, R.D. (1995). The graft survival curve: Ideology and rhetoric —Part II. In: Touraine, J.L., Traeger, J., Bétuel, H., Dubernard, J.M., Revillard, J.P., Dupuy, C. (eds) Organ Shortage: The Solutions. Transplantation and Clinical Immunology, vol 26. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0201-8_30
Download citation
DOI: https://doi.org/10.1007/978-94-011-0201-8_30
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4091-4
Online ISBN: 978-94-011-0201-8
eBook Packages: Springer Book Archive